DNAI INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving ProNAi Therapeutics, Inc. and a Lead Plaintiff Deadline of January 9, 2017

NEW YORK, Dec. 16, 2016 /PRNewswire/ -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of New York on behalf of investors who purchased ProNAi Therapeutics, Inc. DNAI securities between July 15, 2015 and June 6, 2016.

Click here to learn about the case: http://www.wongesq.com/pslra/pronai-therapeutics. There is no cost or obligation to you.

According to the complaint, throughout the Class Period, ProNAi made materially false and misleading statements about the potential and efficacy of its drug product candidate PNT2258 in the company's public filings, which caused ProNAi's stock price to be artificially inflated throughout the Class Period, thus harming investors.

On June 6, 2016, ProNAi revealed that the Phase 2 clinical trials of PNT2258 failed to produce sufficient efficacy results to justify continued clinical development of the drug and, thus, ProNAi was suspending clinical development of PNT2258. Following this news, shares of ProNAi fell more than 67 percent.

If you suffered a loss in ProNAi you have until January 9, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email vw@wongesq.com, by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/pronai-therapeutics.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:    
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/dnai-investor-alert-the-law-offices-of-vincent-wong-reminds-investors-of-a-class-action-involving-pronai-therapeutics-inc-and-a-lead-plaintiff-deadline-of-january-9-2017-300379833.html

SOURCE The Law Offices of Vincent Wong